Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cancer Related Cognitive Decline × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8467 Triple Negative Breast Neoplasms 551 Neoplasms 373 Lung Neoplasms 305 Prostatic Neoplasms 293 Colorectal Neoplasms 259 Ovarian Neoplasms 257 Neoplasm Metastasis 257 Motor Activity 240 Carcinoma, Intraductal, Noninfiltrating 201 Colonic Neoplasms 166 Breast Neoplasms, Male 156 Lymphedema 153 Melanoma 137 Pancreatic Neoplasms 134 Breast Carcinoma In Situ 134 Carcinoma, Non-Small-Cell Lung 133 Fatigue 125 Uterine Cervical Neoplasms 124 Head and Neck Neoplasms 115 Breast Cancer Female 111 Brain Neoplasms 107 Stomach Neoplasms 105 Pain 104 Sarcoma 93 Breast Cancer Lymphedema 93 Depression 90 Anxiety Disorders 87 Lymphoma 85 Cardiotoxicity 79

Interventions

pertuzumab 1 azeliragon 1 Trastuzumab 1 Docetaxel 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05256745 2025-12-24

RAGE

Georgetown University

Phase 1/2 Recruiting

Cancer Related Cognitive Decline

Data powered by HemOnc (CC BY 4.0) Colophon ⚡